NFKB1 and pulmonary arterial hypertension: Additional protective factors include hepatocyte growth factor (HGF) that reduces PAH severity and inflammation by attenuation of NF-kB signaling (8), and suppresses vascular medial hyperplasia and extracellular matrix accumulation (9) in the monocrotaline PAH rat model.